Literature DB >> 11495867

Fat embolization and fatal cardiac arrest during hip arthroplasty with methylmethacrylate.

K M Fallon1, J G Fuller, P Morley-Forster.   

Abstract

PURPOSE: This case report describes a cardiac arrest during a cemented hip arthroplasty procedure. Hemodynamic instability during methylmethacrylate use in arthroplasty surgery can be explained by fat embolization rather than the inherent toxicity of the monomer. CLINICAL FEATURES: A 78-yr-old woman required a cemented hemiarthroplasty for a pathologic left subcapital fracture. The patient's past medical history included stable angina, diet-controlled type II diabetes and metastatic breast cancer. During the cementing of the canal and insertion of the femoral prosthesis, desaturation, hypotension and cardiac arrest occurred. The patient underwent a successful intraoperative resuscitation and was transferred to the intensive care unit where she subsequently developed disseminated intravascular coagulopathy. The patient died 24 hr later and autopsy confirmed the cause of death as fat embolization.
CONCLUSION: The deleterious cardiovascular effects of methylmethacrylate have been discussed in the literature. However, clinical evidence supports fat embolization during arthroplasty surgery as a greater determinant of hemodynamic compromise. Surgical precautions are paramount in minimizing the sequelae of Bone Implantation Syndrome and anesthetic treatment consists of supportive care.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11495867     DOI: 10.1007/BF03016194

Source DB:  PubMed          Journal:  Can J Anaesth        ISSN: 0832-610X            Impact factor:   5.063


  14 in total

1.  Cemented versus uncemented hemiarthroplasty for displaced femoral neck fractures.

Authors:  Wender Figved; Vidar Opland; Frede Frihagen; Tore Jervidalo; Jan Erik Madsen; Lars Nordsletten
Journal:  Clin Orthop Relat Res       Date:  2009-01-07       Impact factor: 4.176

2.  Reversible catastrophic fat embolism: a case report.

Authors:  Kethy Jules-Elysee; Thomas P Sculco
Journal:  HSS J       Date:  2006-02

Review 3.  Cemented versus uncemented hemiarthroplasty for displaced femoral neck fractures: an updated meta-analysis.

Authors:  Guang-Zhi Ning; Yu-Lin Li; Qiang Wu; Shi-Qing Feng; Yan Li; Qiu-Li Wu
Journal:  Eur J Orthop Surg Traumatol       Date:  2012-12-20

4.  An evaluation of peri-operative clinical, serological and radiological parameters in hip arthroplasties -a prospective observational study of Indian cohorts.

Authors:  Atul Panghate; Abhinav D Jogani; Sameer Panchal; Jigar Desai; Nandan Marathe; Rajkumar Rathod
Journal:  J Orthop       Date:  2022-02-17

5.  Does the Risk of Death Within 48 Hours of Hip Hemiarthroplasty Differ Between Patients Treated with Cemented and Cementless Implants? A Meta-analysis of Large, National Registries.

Authors:  Ola E Dahl; Are Hugo Pripp
Journal:  Clin Orthop Relat Res       Date:  2022-02-01       Impact factor: 4.755

6.  Bone cement implantation syndrome: a report of four cases.

Authors:  Pradeep Govil; P N Kakar; Deep Arora; Shibani Das; Nishkarsh Gupta; Deepak Govil; Sachin Gupta; Ashima Malohtra
Journal:  Indian J Anaesth       Date:  2009-04

7.  Complications of cemented long-stem hip arthroplasty in metastatic bone disease revisited.

Authors:  Shawn L Price; M Aabid Farukhi; Kevin B Jones; Stephen K Aoki; R Lor Randall
Journal:  Clin Orthop Relat Res       Date:  2013-06-20       Impact factor: 4.176

8.  Comparative Study of Bipolar Hemiarthroplasty for Femur Neck Fractures Treated with Cemented versus Cementless Stem.

Authors:  Jung-Yun Choi; Yerl-Bo Sung; Joo-Hyung Kim
Journal:  Hip Pelvis       Date:  2016-12-28

9.  Hydroxyapatite coated hip hemiarthroplasty: Morbidity and mortality.

Authors:  Muhammad Ali Fazal; Sunil Shah; Padmanabhan Subramanian
Journal:  J Clin Orthop Trauma       Date:  2020-05-08

Review 10.  Biomarkers of Brain Damage and Postoperative Cognitive Disorders in Orthopedic Patients: An Update.

Authors:  Dariusz Tomaszewski
Journal:  Biomed Res Int       Date:  2015-08-31       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.